Imputation of PaO2 From SaO2
Launched by BRIGHAM AND WOMEN'S HOSPITAL · Nov 4, 2015
Trial Information
Current as of May 05, 2025
Completed
Keywords
ClinConnect Summary
The Sequential Organ Failure Assessment (SOFA) score is validated as a measure of severity of illness over time in intensive care unit (ICU) patients and can be used to follow the course of organ dysfunction and response to treatment1. SOFA has become a frequently used scoring system of patients in multi-organ failure, given its high sensitivity and specificity as a predictor of morbidity and mortality in critically ill patients2. The severity of respiratory dysfunction is measured in the SOFA score by PaO2/FiO2 (PF) ratio, which is also used as a measure of severity of hypoxemia in patient...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Mechanically ventilated patient in a participating ICU or ED.
- • 2. Arterial blood gas ordered and obtained for clinical reasons.
- Exclusion Criteria:
- • 1. Age \< 18 years
- • 2. Pregnancy
- • 3. Prisoners
About Brigham And Women's Hospital
Brigham and Women's Hospital (BWH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As an integral part of the Partners HealthCare system, BWH combines cutting-edge medical education with a focus on patient-centered care, fostering an environment that promotes groundbreaking clinical trials across various specialties. The hospital is dedicated to translating scientific discoveries into effective treatments, making significant contributions to the fields of cardiovascular medicine, oncology, and women's health, among others. With a robust infrastructure for research and a collaborative approach, BWH aims to improve patient outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Beijing, , China
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Peter C Hou, MD
Principal Investigator
Brigham and Women's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials